secwatch.observer — SEC 8-K summary
======================================

Issuer:     Raphael Pharmaceutical Inc. (RAPH)
CIK:        0001415397
Form:       8-K
Filed at:   2025-01-14T23:59:59+00:00
Accession:  0001213900-25-003401
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Raphael Pharmaceuticals appoints Ajay Kumar Dhadha as Director and Chairman, replacing Shlomo Pilo
--------------------------------------------------------------------------------

- Board expanded by one seat; Ajay Kumar Dhadha appointed Director and Chairman effective January 8, 2025.
- Dhadha, age 79, is a diamond dealer, founder/CEO of Shanti Gems (1982) Ltd., and Israel Diamond Exchange member.
- No arrangement, transaction, or reportable relationship exists between Dhadha and the company under Item 404(a).
- Board concluded Dhadha is qualified and independent; standard indemnification agreement to be entered.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1415397/000121390025003401/0001213900-25-003401-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1415397/000121390025003401/ea0227340-8k_raphael.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-003401

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer